- Home
- LFMDP vs RWAYI Comparison
LFMDP vs RWAYI Comparison
Compare LFMDP & RWAYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$23.33
Company Overview
Basic Information| Metric | LFMDP | RWAYI |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2012 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LFMDP | RWAYI |
|---|---|---|
| Price | $23.33 | $24.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.9K | ★ 6.4K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 141.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,468,578.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 49.79 | N/A |
| 52 Week Low | $18.50 | $24.25 |
| 52 Week High | $24.20 | $25.93 |
Technical Indicators
Market Signals| Indicator | LFMDP | RWAYI |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 47.78 |
| Support Level | $23.20 | $24.60 |
| Resistance Level | $23.54 | $24.79 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 12.55 | 51.51 |
Price Performance
Historical Comparison LFMDP
RWAYI
About LFMDP LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.